https://adisinsight.springer.com/trials/700058754?error=cookies_not_supported&code=20177ff0-cab5-422f-b0c3-d4bf0accc700
Non-myeloablative Conditioning Using Pentostatin, Rituximab and Denileukin Diftitox (Ontak) and...
This trial will assess the non myeloablative conditioning using pentostatin, rituximab and denileukin diftitox, interleukin-2, allogeneic natural killer cells
denileukin diftitoxnonconditioningusingrituximab